A US medical research start-up that uses artificial intelligence (AI) to detect diseases has secured 2.25 of funding. Envisagenics is a spin-off from the non-profit private research institute the Cold Spring Harbor Laboratory in New York state, which specialises in molecular biology, neuroscience and genetics. Envisagenics was formed in 2014 and has developed a system that uses machine learning to detect and analyse genetic deformities called splicing errors that can indicate diseases. The investment round was led by venture capital firm Dynamk Capital, and comes after an undisclosed sum received in April from the Thiel Foundation.
A US medical research start-up that uses artificial intelligence (AI) to detect diseases has secured $2.25m of funding. Envisagenics is a spin-off from the non-profit private research institute the Cold Spring Harbor Laboratory in New York state, which specialises in molecular biology, neuroscience and genetics. Envisagenics was formed in 2014 and has developed a system that uses machine learning to detect and analyse genetic deformities called splicing errors that can indicate diseases. The investment round was led by venture capital firm Dynamk Capital, and comes after an undisclosed sum received in April from the Thiel Foundation.